NASDAQ:TGTX is showing decent growth, but is still valued reasonably.

Last update: Aug 7, 2024

Take a closer look at TG THERAPEUTICS INC (NASDAQ:TGTX), an affordable growth stock uncovered by our stock screener. NASDAQ:TGTX boasts strong growth prospects and excels in financial health indicators, all while maintaining a reasonable valuation. Let's break it down further.

Growth Insights: NASDAQ:TGTX

Every stock receives a Growth Rating from ChartMill, ranging from 0 to 10. This rating assesses various growth aspects, including historical and projected EPS and revenue growth. NASDAQ:TGTX boasts a 8 out of 10:

The Earnings Per Share has grown by an impressive 117.89% over the past year.
The Revenue has grown by 3264.48% in the past year. This is a very strong growth!
The Revenue has been growing by 335.01% on average over the past years. This is a very strong growth!
Based on estimates for the next years, TGTX will show a very strong growth in Earnings Per Share. The EPS will grow by 229.97% on average per year.
Based on estimates for the next years, TGTX will show a very strong growth in Revenue. The Revenue will grow by 41.13% on average per year.

Evaluating Valuation: NASDAQ:TGTX

To assess a stock's valuation, ChartMill utilizes a Valuation Rating on a scale of 0 to 10. This comprehensive assessment considers various valuation aspects, comparing price to earnings and cash flows, while factoring in profitability and growth. NASDAQ:TGTX has achieved a 5 out of 10:

Compared to the rest of the industry, the Price/Earnings ratio of TGTX indicates a rather cheap valuation: TGTX is cheaper than 94.60% of the companies listed in the same industry.
TGTX's Price/Forward Earnings ratio is rather cheap when compared to the industry. TGTX is cheaper than 92.86% of the companies in the same industry.
Based on the Enterprise Value to EBITDA ratio, TGTX is valued cheaper than 94.60% of the companies in the same industry.
Based on the Price/Free Cash Flow ratio, TGTX is valued cheaper than 94.77% of the companies in the same industry.
A more expensive valuation may be justified as TGTX's earnings are expected to grow with 419.98% in the coming years.

Health Assessment of NASDAQ:TGTX

ChartMill assigns a Health Rating to every stock. This score ranges from 0 to 10 and evaluates the different health aspects like liquidity and solvency, both absolutely, but also relative to the industry peers. NASDAQ:TGTX scores a 6 out of 10:

TGTX has an Altman-Z score of 3.81. This indicates that TGTX is financially healthy and has little risk of bankruptcy at the moment.
Looking at the Altman-Z score, with a value of 3.81, TGTX is in the better half of the industry, outperforming 77.18% of the companies in the same industry.
TGTX has a better Debt to FCF ratio (5.00) than 95.30% of its industry peers.
A Current Ratio of 3.62 indicates that TGTX has no problem at all paying its short term obligations.
TGTX has a Quick Ratio of 2.84. This indicates that TGTX is financially healthy and has no problem in meeting its short term obligations.

Profitability Assessment of NASDAQ:TGTX

ChartMill assigns a proprietary Profitability Rating to each stock. The score is computed by evaluating various profitability ratios and margins and ranges from 0 to 10. NASDAQ:TGTX was assigned a score of 5 for profitability:

With an excellent Return On Assets value of 11.03%, TGTX belongs to the best of the industry, outperforming 97.74% of the companies in the same industry.
The Return On Equity of TGTX (25.72%) is better than 98.43% of its industry peers.
With an excellent Return On Invested Capital value of 13.96%, TGTX belongs to the best of the industry, outperforming 97.21% of the companies in the same industry.
Looking at the Profit Margin, with a value of 14.23%, TGTX belongs to the top of the industry, outperforming 97.21% of the companies in the same industry.
With an excellent Operating Margin value of 16.71%, TGTX belongs to the best of the industry, outperforming 96.86% of the companies in the same industry.
The Gross Margin of TGTX (93.54%) is better than 94.95% of its industry peers.

More Affordable Growth stocks can be found in our Affordable Growth screener.

For an up to date full fundamental analysis you can check the fundamental report of TGTX

Keep in mind

This is not investing advice! The article highlights some of the observations at the time of writing, but you should always make your own analysis and invest based on your own insights.